Cardiovascular Mortality Associated With Abnormal Calcium Metabolism
NCT00018395 · Status: COMPLETED · Type: OBSERVATIONAL
Last updated 2009-01-21
Summary
The purpose of this cohort study is to estimate the risk of cardiovascular mortality associated with abnormal calcium metabolism
Conditions
Sponsors & Collaborators
-
US Department of Veterans Affairs
lead FED
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1997-08-31
- Completion
- 2002-06-30
Countries
- United States
Study Locations
More Related Trials
-
Effect of Vitamin D3 Supplementation on Arterial and Bone Remodeling in Chronic Kidney Disease Patients
NCT02999204 ·Status: COMPLETED ·Phase: PHASE4
-
Analysis of Calcium Balance in Chronic Kidney Disease
NCT00974532 ·Status: COMPLETED ·Phase: NA
-
Impact of Parathyroidectomy on Cardiovascular Calcification in Dialysis-dependent Patients
NCT03937349 ·Status: COMPLETED
-
Vitamin D and Coronary Calcification Study
NCT00752102 ·Status: COMPLETED ·Phase: PHASE4
-
Renal Artery Calcium and Hypertension
NCT00388869 ·Status: UNKNOWN
-
Vitamin D Deficiency in Chronic Kidney Disease (CKD) Patients
NCT00958451 ·Status: COMPLETED ·Phase: PHASE4
-
An Open Label Trial to Evaluate the Effects of a Novel Renal Multivitamin on Inflammation and Other Biomarkers in Endstage Renal Disease Patients
NCT00834301 ·Status: UNKNOWN ·Phase: PHASE2
-
Aortic Calcification and Vitamin K Antagonists
NCT02823093 ·Status: UNKNOWN
-
Study to Evaluate the Effect of Intravenous (IV) Paricalcitol (Zemplar) on Cardiac Morbidity in Patients With Chronic Kidney Disease (CKD) Stage 5 Over 2 Years
NCT01073462 ·Status: COMPLETED
-
Effect of Etelcalcetide on Cardiac Hypertrophy in Hemodialysis Patients
NCT03182699 ·Status: COMPLETED ·Phase: PHASE4
-
Ergocalciferol in Chronic Kidney Disease
NCT00411294 ·Status: COMPLETED
-
Vitamin D and Arterial Function in Patients With Chronic Kidney Disease
NCT01384539 ·Status: COMPLETED ·Phase: PHASE3
-
Gut Oxalate Absorption in Calcium Oxalate Stone Disease
NCT06331546 ·Status: RECRUITING ·Phase: NA
-
Effect of Neutralization of Endogenous Acid Production on BMD and Bone Microarchitectural
NCT00509405 ·Status: COMPLETED ·Phase: PHASE3
-
Clearance of 25-hydroxyvitamin D in Chronic Kidney Disease
NCT02937350 ·Status: COMPLETED ·Phase: PHASE1
-
Differential Effects of Ergocalciferol and Cholecalciferol Therapies in Chronic Kidney Disease
NCT01835691 ·Status: COMPLETED ·Phase: NA
-
The Effect of REgulation of PArathyroId hoRmone in Patients With Chronic Kidney Disease to Investigate the Change in Bone Mineral Density
NCT07171216 ·Status: RECRUITING ·Phase: NA
-
Sevelamer and Secondary Hyperparathyroidism in Chronic Kidney Disease
NCT01191762 ·Status: COMPLETED ·Phase: PHASE3
-
Underlying Causes of Low Vitamin K Status in Hemodialysis Patients
NCT03493087 ·Status: COMPLETED ·Phase: NA
-
Use of ETElcalcetidefor pReserving vitamiN K-dependent proteIn activiTY ITAlian Study
NCT06352957 ·Status: NOT_YET_RECRUITING
-
Effect of Phosphorus on Valvular and Vascular Calcification in ESRD
NCT03360331 ·Status: UNKNOWN
-
SENSOR: Study to Investigate Cinacalcet Treatment in Haemodialysis Patients With Secondary Hyperparathyroidism
NCT00117052 ·Status: COMPLETED ·Phase: PHASE3
-
Enteric Oxalate Absorption Study in Unclassified Hyperoxaluria
NCT00588120 ·Status: COMPLETED ·Phase: PHASE1
-
Arterial Stiffness and Decreased Bone Buffering Capacity in Hemodialysis Patients
NCT00485706 ·Status: COMPLETED ·Phase: NA
-
Influence of Amlodipine on the Mortality of Patients With End-Stage Renal Failure
NCT00124969 ·Status: COMPLETED ·Phase: PHASE4